This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Endocrine Diseases  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

Richard Trubo

JAMA. 2005;294:1195-1196.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

San Diego—Is the era of insulin injections for patients with diabetes drawing to a close? Probably not, at least not yet. Even so, some researchers exploring alternative delivery systems believe that inhaled insulin is now on the fast track and could emerge as a viable, noninvasive avenue for administering insulin.

For more than 80 years, patients with type 1 and type 2 diabetes have relied on subcutaneous injections as the route for exogenous insulin administration. But inhaled intrapulmonary delivery of insulin appears to be a promising option and perhaps a way to maintain glycemic control without the need for injections before meals. Although inhaled insulin is not a new idea—it was first suggested in the 1920s—encouraging findings from recent studies, including phase 3 trials, captured considerable attention at the American Diabetes Association’s (ADA’s) 65th Scientific Sessions here in June. At a symposium on new insulins, Jay S. . . . [Full Text of this Article]

NEEDLE-FREE INSULIN



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?